NL-OMON22458暂停不适用
Trough level-based dose reduction during infliximab maintenance treatment in Crohn's disease.
Academic Medical Center0 个研究点目标入组 54 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 暂停
- 发起方
- 入组人数
- 54
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Diagnosis of CD based on endoscopy and pathology;
- •2. 18 years or older;
排除标准
- •1. Non-adherence to the 8 weekly infusions schedule in the past;
- •2. Participation in another therapeutic trial;
研究者
相似试验
撤回
4 期
Trough level-based dose reduction during infliximab maintenance treatment in Crohn*s diseaseCrohn's diseaseNL-OMON40729Academisch Medisch Centrum54
Unknown
3 期
The Effect of a Probiotic Preparation (VSL#3) Plus Infliximab in Children With Crohn's DiseaseCrohn's DiseaseNCT01548014Samsung Medical Center1
进行中（未招募）
1 期
A patient guided dose reduction strategy of tyrosine kinase inhibitors in chronic myeloid leukaemiaChronic myeloid leukaemiaMedDRA version: 20.0Level: HLTClassification code 10024296Term: Leukaemias chronic myeloidSystem Organ Class: 100000004851EUCTR2021-006581-20-NLRadboud univeristy medical centre106
已完成
3 期
Dose De-escalation to the Elective Nodal Sites in Head and Neck CancerHead and Neck CancerNCT01812486Universitaire Ziekenhuizen KU Leuven200
已完成
4 期
Adalimumab Dose Reduction Aiming Low Serum Concentration With Control of Disease ActivityRheumatoid ArthritisNCT04222920Reade Rheumatology Research Institute78